Concepedia

Brendan D. Curti

BD

Statistics

Publications

122

Citations

14.2K

H-Index

49

Active since

1968

Affiliations

Providence Portland Medical Center(Current)

The University of Texas MD Anderson Cancer Center

Memorial Sloan Kettering Cancer Center

Moffitt Cancer Center

Dana-Farber Cancer Institute

Brendan D. Curti is an author at Providence Portland Medical Center specializing in oncology, cancer immunotherapy, and immunotherapy.

Publications per year

1968–2025

122

Publications

122

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

Robert H.I. Andtbacka, Howard L. Kaufman, Frances A. Collichio et al. · Journal of Clinical Oncology · 2015 · 2.6K citations · Full text

Medicine, Immunology, Oncology +17

Sunitinib in Patients With Metastatic Renal Cell Carcinoma

Robert J. Motzer, Brian I. Rini, Ronald M. Bukowski et al. · JAMA · 2006 · 1.2K citations

Medicine, Oncology, Pharmacology +17

gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma

Douglas J. Schwartzentruber, David H. Lawson, Jon Richards et al. · New England Journal of Medicine · 2011 · 888 citations

Medicine, Immunology, Oncology +14

Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma

Paul Nathan, Jessica C. Hassel, Piotr Rutkowski et al. · New England Journal of Medicine · 2021 · 878 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

OX40 Is a Potent Immune-Stimulating Target in Late-Stage Cancer Patients

Brendan D. Curti, Magdalena Kovacsovics-Bankowski, Nicholas P. Morris et al. · Cancer Research · 2013 · 509 citations

Medicine, Immunology, Oncology +15

1–5 of 122